Indication · Obstetrics & Gynecology
Pregnancy, labor and postpartum hemorrhage
Last checked: Nov 19, 2026Source: FDA, ClinicalTrials.gov
Devices
487
Cleared or approved since 2000
PMA and De Novo
18
Higher-risk or first-of-kind devices
Breakthrough devices
2
Authorized through June 30, 2026
Recruiting device trials
82
870 device trials in all
Breakthrough-designated devices
- Elecsys sFlt-1 and Elecsys PlGFRoche Diagnostics · 2025
- B·R·A·H·M·S sFlt-1/ PlGF KRYPTOR Test SystemBrahms GmbH, Part of Thermo Fisher Scientific · 2023
Devices
487 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Oxifirst Fetal Oxygen Saturation Monitoring System
Covidien, LLC · PMA · Oximeter, Fetal Pulse · newest 2003 · 5 decisions
- Rapid fFN for the TLiIQ System
Hologic, Inc. · PMA · Enzyme Immunoassay, Fetal Fibronectin · newest 2021 · 3 decisions
- PartoSure Test
Qiagen, Inc. · PMA · Placental Alpha Microglobulin-1 Immunoassay · newest 2019 · 2 decisions
57 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
Universitas IndonesiaAcademic, hospital or other
NCT06436222 · 60 participants · Start May 20, 2024 · Primary completion Dec 31, 2024
Device: HVNI · For: Respiratory Distress, Newborn
Sites: Jakarta Pusat, Indonesia
- Safety and Effectiveness of Different Interface Models for Non-invasive Ventilation Support for Preterm Newborns With a Gestational Age Greater Than or Equal to 28 Weeks.Pivotal-lookingRecruiting
University of Sao Paulo General HospitalAcademic, hospital or other
NCT07944794 · 360 participants (planned) · Start Sep 19, 2025 · Primary completion Nov 30, 2028
Device: Infant Flow; Ram Cannula and 3 more · For: Respiratory Distress Syndrome in Premature Infants; Non Invasive Ventilation (NIV); Nasal Injury
Sites: Feira de Santana, Brazil
South Tees Hospitals NHS Foundation TrustAcademic, hospital or other
NCT04699708 · 150 participants · Start May 15, 2021 · Primary completion Feb 13, 2023
Device: Carbon dioxide monitoring · For: Resuscitation
Sites: Middlesbrough, United Kingdom; Sunderland, United Kingdom
867 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Pump, Breast, Powered (HGX)169
- System, Monitoring, Perinatal (HGM)89
- Visual, Pregnancy Hcg, Prescription Use (JHI)51
- Monitor, Ultrasonic, Fetal (KNG)33
- Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test (NJR)16
- Device, Acupressure (MVV)12
- Clamp, Umbilical (HFW)9
- Instrument, Manual, Specialized Obstetric-Gynecologic (KNA)9
- Intrauterine Tamponade Balloon (OQY)9
- Uterine Electromyographic Monitor (OSP)9
- Extractor, Vacuum, Fetal (HDB)7
- Monitor, Uterine Contraction, External (For Use In Clinic) (HFM)6
- Home Uterine Activity Monitor (LQK)5
- Image Processing Device For Estimation Of External Blood Loss (PBZ)5
- Pump, Breast, Non-Powered (HGY)4
- Forceps, Obstetrical (HDA)3
- Dilator, Cervical, Hygroscopic-Laminaria (HDY)3
- Analyzer, Data, Obstetric (HEO)3
- Electrode, Circular (Spiral), Scalp And Applicator (HGP)3
- Oximeter, Fetal Pulse (MMA)3
- System, Monitoring, For Progress Of Labor (NPB)3
- Catheter, Balloon, Dilation Of Cervical Canal Prior To Labor (PFJ)3
- Gbs Culture Media, Selective And Differential (PQZ)3
- Monitor, Heart Sound, Fetal, Ultrasonic (HEK)2
- Monitor, Heart Rate, Fetal, Ultrasonic (HEL)2
- Monitor, Blood-Flow, Ultrasonic (HEP)2
- Enzyme Immunoassay, Fetal Fibronectin (LKV)2
- Monitor, Fetal Doppler Ultrasound (MAA)2
- Immunoassay For Detection Of Amniotic Fluid Protein(S). (NQM)2
- Immunoassay, Insulin-Like Growth Factor Binding Protein-1 (OAM)2
Research
- Device studies on postpartum hemorrhage across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.